SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Trickle Portfolio

06 Jan 2001 04:04 PM <--
18 Dec 2000 12:33 AM
17 Dec 2000 08:27 PM
30 Oct 2000 11:01 PM

Return to Trickle Portfolio
 
With all the money that has poured into biotech companies in the past year -- estimated to be ~$40 billion -- it is reasonable to expect that suppliers to biotechs should benefit via a trickle down effect. Hence the name. It is estimated that roughly 15% of that is spent on Trickle products for a guesstimated Trickle market size of ~$6 billion. Thats probably conservative. Since there are many types of suppliers, how broadly to define "biotech supplier"/trickle down beneficiary is a toughie. In the interest of diversification, and in catching all the above-mentioned cash, I've defined trickle broadly. Take a glance at the taxonomy below to get an idea of the breadth of my definition.

The portfolio/watchlist and its thread are part index and part trading tool, as well as a forum for trickle news, discussion, and education. Started October 31, 2000.

In the portfolio below, stocks with a value in the # of shares field are owned by the Trickle Portfolio, while the rest are on the watchlist. To qualify for inclusion on the watchlist, a company must have at least 2/3 of its revenue from life science trickle or a very clear trickle bias in its mission statement for the near future as a result of divestiture or strategic shifts. I say life science because a lab is a lab, whether it is in a biotech, a pharma, or an academic/independent institute, and many trickle companies attempt to sell to all three. Many trickle companies have customers in areas of chemistry and instrumentation outside of the life sciences, as their products work well in those disciplines, too. To be purchased by the Trickle Portfolio, a watchlist company must be perceived by me to be a good value versus its potential and to be a 1) category killer, or, 2) successful/very promising niche player, or, 3) buyout candidate. I post my targets and trades for posterity and help. Because of the breadth of the sector as defined, Trickle will make an attempt to keep individual positions below 10% of portfolio assets to keep the weighting representative.

For the fact is that I am very much an amateur at this. I try to compensate with energy, but the quality of discussion is due mostly to the high caliber of the folks who post here with good decorum. Some of these are actual users of trickle products, whose input is especially prized. I am good mostly for trying to ask the right questions, and I am indebted to all of my knowledgeable posters for answers.

Polite discussion and suggestions for picks and targets are invited. You folks know the difference between a reasoned and well-presented rationale for a candidate company's inclusion, and spam, I trust.

Note that this is very much a work in progress. Market size numbers are very rough and very open to discussion. This subject message, the taxonomy, and the links will be refined regularly until I am tired of doing it, or satisfied, whichever comes first. In other words, indefinitely. I will try to let yall know when I do this. Everyones input on all three of those items is welcome.

Here is my humble Trickle Taxonomy. A category is given along links(s) to the industry association(s) representing its players. Subcategories are given along with the websites of companies playing in that space that can be considered fairly pure trickle plays as noted above. Obvious favorites are missing because of a combination of a) being private, &/or b) theyre not pure trickle plays, or c) are owned by a non-tricklish company. When I get this refined to my liking, it will serve as my guide in portfolio management and research. Again, this is an early effort; Ive got a few things scrambled; all help in sorting it out gratefully accepted.

ANALYTICAL INSTRUMENTS(http://www.lpanet.org/)(http://www.asms.org/)
HPLC & RELATED PREP HANDLERS WAT(http://www.waters.com/)
MASS SPECTROMETERS VARI(http://www.varianinc.com/), BDAL(http://www.daltonics.bruker.com/), ABI, WAT
INTERMOLECULAR REACTION ANALYZERS BCOR(http://www.biacore.com/indexanim.html)
SEQUENCERS MDCC, ABI(http://www.appliedbiosystems.com/)
FLUORESCENCE-ACTIVATED CELL SORTERS

BIOINFORMATICS/SOFTWARE INCY(http://www.incyte.com/), PCOP(http://www.pcop.com/)

SMALL MOLECULE LIBRARIES PCOP, SIAL(http://www.sigma-aldrich.com/saws.nsf/Home?OpenFrameset)

HIGH-THROUGHPUT SCREENING ABSC(http://www.aurorabio.com/),CALP(http://www.calipertech.com/), ABI, PBSC(http://www.packardbioscience.com/home4.htm)

REAGENTS, GELS, MEDIA
REAGENTS QGENF(http://www.qiagen.com/), TECH(http://www.rndsystems.com/asp/g_home.asp), IVGN, SIAL, MDCC
GELS, MEDIA IVGN(http://www.invitrogen.com/)

RODENTS/ANIMALS
TRANSGENIC
KNOCKOUT CRL(http://www.criver.com/)

SYNTHESIZERS AGNT(http://www.argotech.com/), ABI

MISC. CHEAPER EQUIPMENT/SUPPLIES
EVAPORATORS NBSC, FSH
FREEZERS NBSC, FSH
SHAKERS NBSC(http://www.nbsc.com/index2.htm), FSH
CENTRIFUGES
PLATE READERS/COUNTERS MDCC(http://www.moldev.com/), BCOR
BALANCES METTLER VIA FSH(http://www3.fishersci.com/main.jsp;$sessionid$2U501KQAAAAC2CWIZEFAAAA)
INCUBATORS
MICROSCOPES NIKON/ZEISS > NBSC, FSH?
FLOW CYTOMETRY
SORTERS & CONSUMABLES

DRUG DISCOVERY (http://www.abrf.org/) MCLS, INCY


Final warning: Usual disclaimers about doing your Due Diligence go double here given my amateur status. I and my Mom own some of these stocks, and I periodically give ownership updates. Further, I often refer to the portfolio anthropomorphically, refer to myself in the third person, and rarely put <g>s after my regular attempts at humor. Dont worry. Im OK, and more normal than you might guess.

Cheers, Tuck